Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-031-5 | CAS number: 10024-93-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 20 March 2017 to 27 April 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- 1992
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Version / remarks:
- 2008
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Soluble rare earth substances are known to give false positives in the LLNA studies.
Test material
- Reference substance name:
- Neodymium trichloride
- EC Number:
- 233-031-5
- EC Name:
- Neodymium trichloride
- Cas Number:
- 10024-93-8
- Molecular formula:
- Cl3Nd
- IUPAC Name:
- neodymium trichloride
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Appearance: white powder
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Batch No.of test material: NDCL16-60
- Expiration date of the lot/batch: 09 February 2018
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 4 to 5 weeks old
- Weight at study initiation: 327 to 396 g
- Housing: in groups of up to 3 in polycarbonate containers, the flooring of which was covered with dust-free cuttings and the top fitted with a stainless steel lid with a feeding device and drinking device of 500 mL.
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: minimum of 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: 19 to 25°C
- Humidity: 30 to 70%
- Air changes: at least 10 per hour
- Photoperiod: lighting was controlled by a time switch to give twelve hours continuous light (07.00 to 19.00) and twelve hours darkness.
Study design: in vivo (non-LLNA)
Induction
- Route:
- other: intradermal and topical
- Vehicle:
- other: physiological saline (intradermal) and water (topical)
- Concentration / amount:
- 0.02 % w/v (intradermal) and 80 % w/v (topical)
- Day(s)/duration:
- Intradermal induction took place on Day 0. On Day 8, animals received a topical induction application which was covered for 48 hours.
- Adequacy of induction:
- non-irritant substance, but skin pre-treated with 10% SDS
Challenge
- No.:
- #1
- Route:
- other: topical
- Vehicle:
- water
- Remarks:
- distilled
- Concentration / amount:
- 10 % and 20 % (1 sample cup)
- Day(s)/duration:
- 14 days after the topical induction dose (Day 21), animals were exposed to the challenge dose for 24 hours.
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- Group 1 (Negative control): n=5
Group 2 (Treatment group): n=10 - Details on study design:
- PRELIMINARY TESTS:
-Determination by intradermal injection of the Maximal Non Necrotizing Concentration (MNNC):
This test was conducted for the purpose of defining a MNNC of the test material which, on intradermal injection during the induction phase, does not risk causing too great a lesion (non-necrotizing concentration), should be well-tolerated systemically and should be the highest to cause mild-to-moderate skin irritation.
Two animals received a volume of 0.1 mL of the test material, on both sides of the spine, at 4 concentrations: diluted at 60, 40, 20 and 5% in physiological saline in view to determine the MNNC. A macroscopic evaluation of the cutaneous reactions was conducted 24 hours after the injections. Due to the necrosis observed in the animals, the same animals received a volume of 0.1 mL of the test material, on both sides of the spine at 4 new concentrations: diluted at 2, 1, 0.5 and 0.2% in physiological saline in view to determine the MNNC. A macroscopic evaluation of the cutaneous reactions was conducted 24 hours after the injections. Due to the necrosis observed in the animals, the same animals received a volume of 0.1 mL of the test material, on both sides of the spine at 4 new concentrations: diluted at 0.1, 0.05, 0.02 and 0.01% in physiological saline in view to determine the MNNC. A macroscopic evaluation of the cutaneous reactions was conducted 24 hours after the injections.
- Determination by topical application of the Pre-Maximal Non Irritant Concentration (Pre-MNIC):
This test, which allowed evaluating the irritancy potential of the test material, defined whether an application of sodium lauryl sulphate would be needed during topical induction phase.
The test material was applied on the dorso-lumbar zone of two guinea pigs shorn beforehand, with occlusive dressing for 24 hours, at 4 different concentrations: diluted at 80, 50, 30 and 20% in distilled water. After the removal of the occlusive dressing, the treated areas were rinsed with distilled water. A macroscopic evaluation of the cutaneous reactions was conducted 24 hours after removal of the dressing.
- Determination by topical application of the Maximal Non Irritant Concentration (MNIC):
This test was carried out for the purpose of determining the MNIC of the test material without risk of an irritant effect during the challenge phase.
Three guinea pigs were treated according to the same treatment as animals from GROUP 1 (control) for the induction phase (i.e. physiological saline and distilled water). During the challenge phase, the animals were treated with the test material placed onto the selected treatment sites and covered with an occlusive dressing for a period of 24 hours at 4 different concentrations: diluted at 80, 70, 60 and 50% in distilled water. After the removal of the occlusive dressing, the treated areas were rinsed with distilled water. A macroscopic evaluation of the cutaneous reactions was conducted 24 and 48 hours after removal of the occlusive dressing. Due to the results, the same animals were treated with the test material placed onto the selected treatment sites and covered with an occlusive dressing for a period of 24 hours at 4 new different concentrations: diluted at 40, 20, 10 and 5% in distilled water. A macroscopic evaluation of the cutaneous reactions was conducted 24 and 48 hours after removal of the occlusive dressing.
MAIN STUDY
A. INDUCTION EXPOSURE
- Intradermal induction
Day 0: After shearing the scapular zone, three pairs of intradermal injections (ID) of 0.1 mL were performed on the scapular zone in such a way as an injection on each pair is placed to either side of the spine as follows:
GROUP 1 (control):
2 ID: Freund’s Complete Adjuvant diluted at 50% in physiological saline
2 ID: physiological saline
2 ID: a mixture with equal volumes v/v:
- Freund’s Complete Adjuvant at 50% and physiological saline
GROUP 2 (Treated):
2 ID: Freund’s Complete Adjuvant diluted at 50% in physiological saline
2 ID: test material at 0.02% in physiological saline
2 ID: a test mixture in equal volumes v/v:
- Freund’s Complete Adjuvant at 50 % and the test material at 0.04% in physiological saline
- Topical induction
Day 7: The scapular zone of all the animals in each group, shorn beforehand, was brushed with a solution of sodium lauryl sulphate at 10% in thick Vaseline, in order to create a local irritation.
Day 8: A topical application under occlusive dressing (25 mm x 25 mm non-woven swab of 4-layer patch held in contact with the skin by means of 50 mm wide hypoallergenic adhesive tape) for 48 hours was performed on the injection sites of each animal:
GROUP 1 (control): 0.5 mL of distilled water.
GROUP 2 (treated): 0.5 mL of the test material at 80% in distilled water.
Day 10: Removal of the semi-occlusive dressing.
- Rest phase: The animals of both groups were left for 10 days.
B. CHALLENGE EXPOSURE
Day 21: The experimental procedure of this phase was identical for both groups submitted to this experimentation: on the previously shorn dorso-lumbar zone, an application, under occlusive dressing, was applied for 24 hours:
- 1 sample cup saturated with the test material at 20 % (MNIC) and 1 sample cup saturated with the test material at 10% in distilled water (1/2 MNIC).
Day 22: After the removal of the occlusive dressing, the treated areas were rinsed with distilled water.
Day 23: 1st reading time – 24 hours after the patch removal.
Day 24: 2nd reading time – 48 hours after the patch removal.
INTERPRETATION OF RESULTS
The test material will be regarded as a sensitiser if 30% or more of the test animals show a sensitisation response:
Sub-category 1A: ≥ 30 % responding at ≤ 0.1 % intradermal induction dose or ≥ 60 % responding at > 0.1 % to ≤ 1 % intradermal induction dose
Sub-category 1B: ≥ 30 % to < 60 % responding at > 0.1 % to ≤ 1 % intradermal induction dose or ≥ 30 % responding at > 1 % intradermal induction dose - Challenge controls:
- Yes, administered the test material in distilled water at a challenge concentration of 20 and 10% w/v
- Positive control substance(s):
- yes
- Remarks:
- α-hexylcinnamaldehyde
Results and discussion
- Positive control results:
- Under these experimental conditions, the reference substance a-Hexylcinnamaldehyde must be classified in category 1 “Skin sensitisation” sub-category 1B in accordance with the Regulation EC No. 1272/2008 on classification, labelling and packaging of substances and mixtures. The signal word “Warning” and hazard statement H317 “May cause an allergic skin reaction” are required.
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 20 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 20 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 20 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 20 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
Any other information on results incl. tables
PRELIMINARY STUDIES
- MNNC determination:
Necrosis in all animals was observed at the tested concentrations of 60, 40, 20 and 5%. In view of these results, another MNNC determination was carried out at the tested concentrations of 2, 1, 0.5 and 0.2%.
24 hours after the injections, necrosis was observed in all animals at the tested concentrations of 2, 1, 0.5 and 0.2%.
In view of these results, another MNNC determination was carried out at the tested concentrations of 0.1, 0.05, 0.02 and 0.01%.
24 hours after the injections, necrosis was observed in one animal (1/2) at the tested concentration of 0.1% and slight necrosis was observed in the other animal. Slight necrosis was observed in all animals at the tested concentration of 0.05%. Discrete erythema was noted in the animals at the tested concentrations of 0.02 and 0.01%. The first induction of the Group 2 was carried out by intradermal injection at the maximal non necrosing concentration of 0.02%.
- Pre MNIC determination:
24 hours after the removal of the occlusive dressings, no cutaneous reaction was observed whatever the tested concentration. In view of these results, the concentration selected was 80% for the 2nd induction of the Group 2 and the MNIC determination began at the concentration of 80%.
- MNIC determination:
24 hours after the removal of the occlusive dressings, moderate to intense erythema was notedat the tested concentrations of 80, 70, 60 and 50%.
48 hours after the removal of the occlusive dressings, discrete to moderate erythema associated with dryness of the skin was notedat the tested concentrations of 80, 70, 60 and 50%.
In view of these results, another MNIC determination was carried out at the tested concentrations of 40, 20, 10 and 5%.
24 hours after the removal of the occlusive dressings, discrete erythema was noted in the animals at the tested concentrations of 40% and no cutaneous reaction was noted at the tested concentrations 20, 10 and 5%.
48 hours after the removal of the occlusive dressings, no cutaneous reaction was noted whatever the tested concentration. In view of this result, the concentrations selected were 20% (MNIC) and 10% (1/2 MNIC) for the challenge phase.
MAIN STUDY
-Induction phase Group 2: Discrete erythema was noted in four animals (4/10) and no cutaneous reaction was noted in six animals (6/10) 24 hours after the first induction. Discrete erythema associated with dryness of the skin was noted in all animals (10/10) after the second induction.
- Induction phase Group 1: No cutaneous reaction was noted 24 hours after the first induction. Dryness of the skin was noted in all animals (5/5) after the second induction.
- Challenge phase Groups 1 & 2: Overall results of the challenge phase with the test material (readings at 24 and 48 hours) are given in Table 1.
In the treated group (treatment dose of 20%), no macroscopic cutaneous reactions attributable to allergy were noted after the challenge phase. In the control group (associated with the treatment dose of 20%), no macroscopic cutaneous intolerance reactions were recorded after the challenge phase.
In the treated group (treatment dose of 10%), no macroscopic cutaneous reactions attributable to allergy were noted after the challenge phase. In the control group (associated with the treatment dose of 10%), no macroscopic cutaneous intolerance reactions were recorded after the challenge phase.
WEIGHT EVOLUTION
No abnormality was recorded in the body weight gain of both groups.
MORTALITY
No mortality was registered during the main test.
Table 1: Macroscopic evaluation (readings at 24 and 48 hours) of cutaneous reactions
Groups |
Reading time |
Concentrations |
Incidence |
% of positive responses ≥ 1 |
% of animal sensitised |
|||
0 |
1 |
2 |
3 |
|||||
Group 1 Control |
24 h |
20 % |
5 |
0 |
0 |
0 |
0 |
- |
48 h |
20 % |
5 |
0 |
0 |
0 |
0 |
- |
|
24 h |
10 % |
5 |
0 |
0 |
0 |
0 |
- |
|
48 h |
10 % |
5 |
0 |
0 |
0 |
0 |
- |
|
Group 2 Treated |
24 h |
20 % |
10 |
0 |
0 |
0 |
0 |
0 |
48 h |
20 % |
10 |
0 |
0 |
0 |
0 |
0 |
|
24 h |
10 % |
10 |
0 |
0 |
0 |
0 |
0 |
|
48 h |
10 % |
10 |
0 |
0 |
0 |
0 |
0 |
Grading scale
0 = No visible change
1 = Discrete or patchy erythema
2 = Moderate and confluent erythema
3 = Intense erythema and swelling
Applicant's summary and conclusion
- Interpretation of results:
- other: Not sensitising in accordance with EU criteria
- Conclusions:
- Under the conditions of the study, the test material is not considered to be a skin sensitiser.
- Executive summary:
The potential of the test material to cause sensitisation was determined in accordance with the standardised guidelines OECD 406 and EU Method B6 under GLP conditions using the guinea pig maximisation test.
According to the results of the pre-tests, the test material was applied to 10 Guinea pigs during the induction phase (intradermic injection at 0.02% and topical application at 80%). During the challenge phase, animals received a topical application of test material (diluted at 20% and 10% in distilled water) under an occlusive dressing for a period of 24 hours.
In the treated group (treatment dose of 20%), no macroscopic cutaneous reactions attributable to allergy were noted after the challenge phase. In the control group (associated with the treatment dose of 20%), no macroscopic cutaneous intolerance reactions were recorded after the challenge phase.
In the treated group (treatment dose of 10%), no macroscopic cutaneous reactions attributable to allergy were noted after the challenge phase. In the control group (associated with the treatment dose of 10%), no macroscopic cutaneous intolerance reactions were recorded after the challenge phase.
The results of the positive control test validate the test.
In conclusion, under the conditions of this study the test material is not classified as a skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)